Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

Genes Chromosomes and Cancer

Volumn 43, Issue 3, 2005, Pages 309-313

  Hendrickson, Brant C ^a   Judkins, Thaddeus ^a   Ward, Benjamin D ^a   Eliason, Kristilyn ^a   Deffenbaugh, Amie E ^a   Burbidge, Lynn Anne ^a   Pyne, Kristin ^a   Leclair, Benoît ^a   Ward, Brian E ^a   Scholl, Thomas ^a  

^a Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; ETHNOLOGY; EXON; FAMILIAL CANCER; GENE DUPLICATION; GENE IDENTIFICATION; GENE MUTATION; GENE REARRANGEMENT; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; ONCOGENE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EXONS; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; GENES, BRCA1; HUMANS; MUTATION; OVARIAN NEOPLASMS; REFERENCE VALUES; SEQUENCE DELETION;

EID: 21144436491     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20189     Document Type: Article

References (19)

1. Barrois M, Bieche I, Mazoyer S, Chanpeme M-H, Bressac-de Pailleret B, Lidereau R. 2004. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families. Clin Genet 65:131-136.
2. BRCA1 Duplication of Exon 13 Screening Group. 2000. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 67:207-212.
3. Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M. 2002. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mut 20:218-216.
4. Eng C, Brody LC, Wagner TMU, Devilee P, Vijg J, Szabo C, Tavtigian S, Nathanson KL, Ostrander E, Frank TS. 2001. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 38:824-833.
5. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frenay M, Gilbert B, Maugard C, Bignon Y-J, Chevrier A, Rossi A, Flicker J-P, Nguyen TD, Demange L, Aurias A, Bensimon A, Stoppa-Lyonnet D. 2002. Significant contribution of large BRCA1 rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841-6847.
6. Hendrickson BC, Pruss D, Deffenbaugh AM, Nielsen DR, Gaglio CA, Scholl T. 2001. Identification of large genomic deletions in BRCA1 from patients with hereditary cancer risk using SNP haplotype pair analysis derived from clinical sequence data. Am J Hum Genet 69:263 (supplement).
7. Hendrickson BC, Pruss D, Lyon E, Scholl T. 2003. Application of haplotype pair analysis for the identification of hemizygous loci. J Med Genet 40:346-347.
8. Hogervorst FBL, Nederlof PM, Gille JP, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Weisem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G. 2003. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453.
9. Montagna M, Santacatterina M, Torri A, Menin C, Zullato D, Chieco-Bianchi L, D'Andrea E. 1999. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 18:4160-4165.
10. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, Wasen HFA, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen G-JB, Devilee P. 1997. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341-345.
11. Puget N, Torchard D, Serova-Sinilikova OM, Lynch HT, Feunteun J, Lenour GM, Mazoyer S. 1997. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 57:828-831.
12. Puget N, Stoppa-Lyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM, Mazoyer S 1999a. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455-461.
13. Puget N, Sinilnikova OM, Stoppa-Lyonnet D, Audoynaud C, Pages S, Lynch HT, Goldgar D, Lenoir GM, Mazoyer S. 1999b. An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64:300-302.
14. Rohlfs EM, Puget N, Graham ML, Weber BL, Garber JE, Skrzynia C, Halperin JL, Lenoir GM, Silverman LM, Mazoyer S. 2000. An Alu-mediated 7.1kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28:300-307.
15. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenbug D, Diepvens F, Pals G. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucl Acids Res 30:e57.
16. Swensen J, Hoffman M, Skolnick MH, Neuhausen SL. 1997. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 6:1513-1517.
17. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin A-M, Lenoir GM, Mazoyer S, Weber BL. 2000. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841-850.
18. Ward BD, Hendrickson BC, Judkins T, Deffenbaugh AM, Leclair B, Ward BE, Scholl T. 2005. A multi-exonic BRCA1 deletion identified in multiple families through SNP haplotype pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 7:139-142.
19. Yau SC, Bobrow M, Mathew CG, Abbs SJ. 1996. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 33:550-558.